"Achieving MDR CE Mark is a significant milestone in Radformation's mission to advance global cancer care," said Kurt Sysock, CEO at Radformation. "We are excited to bring our solutions to CE mark ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...

A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...

Recently, actress Danielle Fishel posted online about her very painful reaction to radiation during treatment for breast ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 (GLOBE NEWSWIRE) -- (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from antibody engineering company ...